Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone therapy may slightly increase sexual desire in women with HSDD but lacks broad recommendation due to safety concerns and limited approval.

Hormone therapy may increase migraines in transgender women and decrease them in transgender men; more research is needed on migraine management in transgender individuals.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

The document concludes that accurate diagnosis of male and female gonadal disorders is crucial for effective treatment and better patient outcomes.

The document explains how male reproductive hormones work and affect the body.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Statins may help treat PCOS by lowering androgen levels and improving cholesterol.

The document suggests that blocking sweat glands with antiperspirants might allow skin-generated hormones to be absorbed, possibly increasing breast and prostate cancer risk.

Vitamin D and estrogen may help protect heart and kidney health, and maintaining sufficient vitamin D levels could be especially beneficial for African Americans, postmenopausal women, and people with chronic kidney disease.

The enzyme 17β-HSD type 2 mainly performs oxidation in human sebaceous glands, which may help protect against acne.

Thyrotropin-Releasing Hormone helps heal wounds in frog and human skin.

Certain gene variants may contribute to high androgen levels in women with polycystic ovary syndrome.

Women with PCOS have different levels of certain fats and proteins in their blood, which could help diagnose the condition.

The definition of Polycystic Ovary Syndrome may change with new research, and careful screening is key for managing the condition.

Hirsute women have lower type 2 17β-HSD enzyme levels, which improve with treatment.

Estrogen loss during menopause worsens skin health, but hormone replacement therapy may improve it, though more research is needed.

Family-based treatment is the best outpatient care for stable teens with anorexia, and more research is needed on medication and treatment effectiveness for young people with eating disorders.

Premature ovarian insufficiency (POI) can harm women's sexual health, and they may benefit from hormone therapy and counseling.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Estrogen replacement can improve skin health in menopausal women but doesn't reverse sun damage or prevent hair loss.

The new oral testosterone pill normalized testosterone levels and lowered SHBG in men with low testosterone.

SHBG binding properties are unchanged in male liver cirrhosis patients.

GnRH analogues are effective for diagnosing and treating female androgen excess, offering a non-surgical option.

Removing both ovaries treated the woman's excess male hormone symptoms.

Tamoxifen effectively treats gynecomastia without causing impotence.

DHT's role in hair loss is important, but measuring its level for diagnosis is questionable.

Eating high-glycemic and dairy foods can increase hormones that may cause acne and other health issues.

Finasteride in male rats causes liver and metabolic issues in their offspring.

A new mutation in the DCAF17 gene was found in a Chinese family, causing Woodhouse-Sakati syndrome and diabetes.